156 related articles for article (PubMed ID: 29747817)
1. Gangliosides in Inflammation and Neurodegeneration.
Furukawa K; Ohmi Y; Tajima O; Ohkawa Y; Kondo Y; Shuting J; Hashimoto N; Furukawa K
Prog Mol Biol Transl Sci; 2018; 156():265-287. PubMed ID: 29747817
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice.
Ohmi Y; Tajima O; Ohkawa Y; Yamauchi Y; Sugiura Y; Furukawa K; Furukawa K
J Neurochem; 2011 Mar; 116(5):926-35. PubMed ID: 21214571
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord.
Ohmi Y; Ohkawa Y; Tajima O; Sugiura Y; Furukawa K; Furukawa K
J Neuroinflammation; 2014 Mar; 11():61. PubMed ID: 24673754
[TBL] [Abstract][Full Text] [Related]
4. Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues.
Ohmi Y; Ohkawa Y; Yamauchi Y; Tajima O; Furukawa K; Furukawa K
Neurochem Res; 2012 Jun; 37(6):1185-91. PubMed ID: 22488331
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms of nervous systems with glycosphingolipids.
Furukawa K; Ohmi Y; Ohkawa Y; Tokuda N; Kondo Y; Tajima O; Furukawa K
Neurochem Res; 2011 Sep; 36(9):1578-86. PubMed ID: 21562747
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.
Ohmi Y; Tajima O; Ohkawa Y; Mori A; Sugiura Y; Furukawa K; Furukawa K
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22405-10. PubMed ID: 20018737
[TBL] [Abstract][Full Text] [Related]
7. Novel Molecular Mechanisms of Gangliosides in the Nervous System Elucidated by Genetic Engineering.
Furukawa K; Ohmi Y; Yesmin F; Tajima O; Kondo Y; Zhang P; Hashimoto N; Ohkawa Y; Bhuiyan RH; Furukawa K
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168753
[TBL] [Abstract][Full Text] [Related]
8. Glycolipids: Essential regulator of neuro-inflammation, metabolism and gliomagenesis.
Furukawa K; Ohmi Y; Ji S; Zhang P; Bhuiyan RH; Ohkawa Y; Tajima O; Hashimoto N; Furukawa K
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2479-2484. PubMed ID: 28602513
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic role of ganglioside metabolism in neurodegenerative diseases.
Ariga T
J Neurosci Res; 2014 Oct; 92(10):1227-42. PubMed ID: 24903509
[TBL] [Abstract][Full Text] [Related]
10. Lipid Rafts from Olfactory Ensheathing Cells: Molecular Composition and Possible Roles.
Campos FSO; Piña-Rodrigues FM; Reis A; Atella GC; Mermelstein CS; Allodi S; Cavalcante LA
Cell Mol Neurobiol; 2021 Apr; 41(3):525-536. PubMed ID: 32415577
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts: keys to neurodegeneration.
Schengrund CL
Brain Res Bull; 2010 Apr; 82(1-2):7-17. PubMed ID: 20206240
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of gangliosides in neurodevelopment: an overview of recent advances.
Yu RK; Tsai YT; Ariga T
Neurochem Res; 2012 Jun; 37(6):1230-44. PubMed ID: 22410735
[TBL] [Abstract][Full Text] [Related]
13. [Physiological and pathological roles of gangliosides].
Mrówczyńska L; Mrówczyński W
Postepy Hig Med Dosw (Online); 2013 Sep; 67():938-49. PubMed ID: 24088537
[TBL] [Abstract][Full Text] [Related]
14. The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.
Ariga T
Mol Neurobiol; 2017 Jan; 54(1):623-638. PubMed ID: 26748510
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides of the Nervous System.
Ledeen R; Wu G
Methods Mol Biol; 2018; 1804():19-55. PubMed ID: 29926403
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
Sipione S; Monyror J; Galleguillos D; Steinberg N; Kadam V
Front Neurosci; 2020; 14():572965. PubMed ID: 33117120
[TBL] [Abstract][Full Text] [Related]
17. Mastoparan changes the cellular localization of Galphaq/11 and Gbeta through its binding to ganglioside in lipid rafts.
Sugama J; Ohkubo S; Atsumi M; Nakahata N
Mol Pharmacol; 2005 Nov; 68(5):1466-74. PubMed ID: 16118364
[TBL] [Abstract][Full Text] [Related]
18. Multi-system disorders of glycosphingolipid and ganglioside metabolism.
Xu YH; Barnes S; Sun Y; Grabowski GA
J Lipid Res; 2010 Jul; 51(7):1643-75. PubMed ID: 20211931
[TBL] [Abstract][Full Text] [Related]
19. Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.
Grassi S; Giussani P; Mauri L; Prioni S; Sonnino S; Prinetti A
J Lipid Res; 2020 May; 61(5):636-654. PubMed ID: 31871065
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts and human diseases: why we need to target gangliosides.
Fantini J
FEBS Open Bio; 2023 Sep; 13(9):1636-1650. PubMed ID: 37052878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
